Ironwood Pharmaceuti (IRWD) Stock Price, Quote & News

Company Profile

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA na...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 617 621 7722

Fax: 617 494 0480

Website: ironwoodpharma.com

Address:

100 Summer Street, Suite 2300, Boston, United States

VSTN Feb. 5 at 9:02 PM

$IRWD I’m convinced Goldman Sachs has a intern on this and is being paid by the hour.

0 · Reply

VSTN Feb. 5 at 8:42 PM

$IRWD doesn’t look like she’s making it alive today

0 · Reply

ZacksResearch Feb. 5 at 6:20 PM

$IRWD is setting up a bullish 2026 narrative — and Linzess could be the driver 👀 Management expects Linzess demand to accelerate, supporting a bullish 2026 outlook with revenue growth, higher profits, and expanding adoption. Find out what’s behind the bullish view and why adoption trends matter 👉 https://www.zacks.com/stock/news/2829660/does-ironwoods-bullish-2026-view-signal-greater-linzess-adoption?cid=sm-stocktwits-2-2829660-teaser-32178&ADID=SYND_STOCKTWITS_TWEET_2_2829660_TEASER_32178

0 · Reply

ZacksResearch Feb. 5 at 5:20 PM

$IRWD skyrocketed 457.2% in 6 months against the industry’s decline of 0.3% — what’s fueling this surge? 🚀 📈 Strong demand for Linzess drives momentum 💼 2026 revenue projected to rise 54% YoY 📊 Adjusted EBITDA expected to surpass $300M in 2026 See why Ironwood is a Zacks Rank #1 stock 👉 https://www.zacks.com/stock/news/2829660/does-ironwoods-bullish-2026-view-signal-greater-linzess-adoption?cid=sm-stocktwits-2-2829660-body-32177&ADID=SYND_STOCKTWITS_TWEET_2_2829660_BODY_32177

0 · Reply

Scizz413 Feb. 5 at 1:32 PM

$IRWD 📈🏦💪🏻 If you got in here lets go celebrate together!!

0 · Reply

P2W6zero Feb. 5 at 10:27 AM

$IRWD as far as i can see mc starting to get lower and lower. Few days ago 850m and now ‪729.61 M = 120M cut

0 · Reply

revuelto Feb. 5 at 9:21 AM

$IRWD why its mc isn’t closer to ~$1.3B ahead of a p3 apra design or a potential acquisition announcement is beyond me…..McCourt and Denner, it’s time to get to work 👍

0 · Reply

DimebagDarrell_ Feb. 5 at 4:00 AM

$ALLO Will we see a $IRWD move here?

0 · Reply

buymoremakemore Feb. 4 at 11:54 PM

$IRWD I just am praying this delayed update on the phase 3 trial has a good reason to it. I guess if it were that bad theyd rip the bandaid off and make a PR. I think theyre smart enough to know they cant bury it in the earnings PR if its bad. The amount of revnue a buyer can make for linzess alone before patent expires and there starts to be erosion is staggering compared to what a fair buyout price is. Denner must be the biggest douchebag on the planet.

1 · Reply

RunnerSignals Feb. 4 at 11:04 PM

$SOFI $NET $IRWD $FIVE got upgrades today. big moves brewing so... don’t blink or you'll miss the action! https://stocksrunner.com/news/2026-02-04-top-stock-upgrades-today

0 · Reply

Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance

Nov 26, 2025, 4:03 PM EST - 2 months ago

Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025

Nov 10, 2025, 7:05 AM EST - 3 months ago

Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Oct 24, 2025, 8:10 AM EDT - 3 months ago

Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta

Aug 7, 2025, 7:05 AM EDT - 6 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

May 7, 2025, 7:05 AM EDT - 9 months ago

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

Apr 30, 2025, 4:25 PM EDT - 10 months ago

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 25, 2025, 7:05 AM EDT - 10 months ago

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Apr 22, 2025, 4:05 PM EDT - 10 months ago

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Apr 14, 2025, 2:19 PM EDT - 10 months ago

Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug

Apr 14, 2025, 7:00 AM EDT - 10 months ago

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Apr 10, 2025, 10:49 AM EDT - 10 months ago

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Mar 25, 2025, 8:30 AM EDT - 11 months ago

Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund

Feb 27, 2025, 11:21 AM EST - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 1 year ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Feb 20, 2025, 4:00 PM EST - 1 year ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Jan 29, 2025, 4:05 PM EST - 1 year ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Jan 17, 2025, 8:07 AM EST - 1 year ago

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Nov 26, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 13, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Nov 7, 2024, 10:34 PM EST - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 1 year ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Oct 28, 2024, 7:00 AM EDT - 1 year ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Oct 24, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

Aug 29, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

Aug 9, 2024, 12:10 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Jul 25, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Jun 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation

Jun 26, 2024, 3:30 PM EDT - 1 year ago

The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue

Jun 25, 2024, 2:45 PM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact

Jun 24, 2024, 4:45 PM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication

Jun 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect

Jun 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out

Jun 20, 2024, 1:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC

Jun 19, 2024, 4:20 PM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact

Jun 18, 2024, 4:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 11, 2024, 7:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 9, 2024, 11:00 AM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Urges Investors With Losses To Contact Them

Jun 8, 2024, 11:00 AM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch

Jun 7, 2024, 3:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Contact Them

Jun 6, 2024, 1:00 PM EDT - 1 year ago

Accusations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Investigation And Invites Investors With Losses To Reach Out

Jun 5, 2024, 1:30 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect

Jun 4, 2024, 3:00 PM EDT - 1 year ago

The Schall Law Firm Declares an Inquiry into Accusations Against Ironwood Pharmaceuticals, Inc. and Advocates for Investors with Losses to Reach Out

Jun 2, 2024, 11:00 AM EDT - 1 year ago

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 31, 2024, 6:15 PM EDT - 1 year ago

ONGOING INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 30, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

VSTN Feb. 5 at 9:02 PM

$IRWD I’m convinced Goldman Sachs has a intern on this and is being paid by the hour.

0 · Reply

VSTN Feb. 5 at 8:42 PM

$IRWD doesn’t look like she’s making it alive today

0 · Reply

ZacksResearch Feb. 5 at 6:20 PM

0 · Reply

ZacksResearch Feb. 5 at 5:20 PM

0 · Reply

Scizz413 Feb. 5 at 1:32 PM

$IRWD 📈🏦💪🏻 If you got in here lets go celebrate together!!

0 · Reply

P2W6zero Feb. 5 at 10:27 AM

$IRWD as far as i can see mc starting to get lower and lower. Few days ago 850m and now ‪729.61 M = 120M cut

0 · Reply

revuelto Feb. 5 at 9:21 AM

$IRWD why its mc isn’t closer to ~$1.3B ahead of a p3 apra design or a potential acquisition announcement is beyond me…..McCourt and Denner, it’s time to get to work 👍

0 · Reply

DimebagDarrell_ Feb. 5 at 4:00 AM

$ALLO Will we see a $IRWD move here?

0 · Reply

buymoremakemore Feb. 4 at 11:54 PM

1 · Reply

RunnerSignals Feb. 4 at 11:04 PM

$SOFI $NET $IRWD $FIVE got upgrades today. big moves brewing so... don’t blink or you'll miss the action! https://stocksrunner.com/news/2026-02-04-top-stock-upgrades-today

0 · Reply

Facade78 Feb. 4 at 8:40 PM

$IRWD Will drop to 3.8?

1 · Reply

flyinghollaender Feb. 4 at 6:39 PM

$IRWD if i would have more cash to spend right now i would invest in irwd. Nice dip to buy

0 · Reply

Solaf Feb. 4 at 5:40 PM

$IRWD dear incompetent management, take your time until the market implodes.

1 · Reply

P2W6zero Feb. 4 at 5:25 PM

$IRWD Wonder if next report date February 12 will change anything

0 · Reply

BalanceBloom Feb. 4 at 3:35 PM

$IRWD is a pharmaceutical company (Ironwood Pharmaceuticals) with a drug for IBS-C; it faces patent expiration and needs to diversify its revenue base.

0 · Reply

P2W6zero Feb. 4 at 3:18 PM

$IRWD if we get so many good info, why does it go so low today ? it goes down 1$ since 2 weeks 5.50 to 4.50

1 · Reply

VSTN Feb. 4 at 3:02 PM

$IRWD A sea of red

0 · Reply

buymoremakemore Feb. 4 at 2:48 PM

$IRWD analysts set the eatimate to 969M. Way above IRWD guidance. 907M not good enough. Crooks. Buy dip

0 · Reply

Sareptaking Feb. 4 at 1:01 PM

$IRWD 907M net revenue for the year in linzess sales for $ABBV

1 · Reply

revuelto Feb. 3 at 11:05 PM

$IRWD tomorrow is AbbVie’s day pre-market…I don’t expect any meaningful price action around the event for Ironwood but we will see…we are only about two months from the end of q1, so timing is starting to matter✌️

1 · Reply

ASKING7 Feb. 3 at 8:06 AM

$IRWD Just found it interesting for that 1 hour period, where did the 1.1 million shares go?

0 · Reply

revuelto Jan. 30 at 3:11 PM

$IRWD not every day is a hay day, just saying….but when the hay shows up there will be plenty of it 🥳✌️

1 · Reply

Market Cap	729.62M
Revenue (ttm)	351.41M
Net Income (ttm)	880,000.00
EPS (ttm)	N/A
PE Ratio	18.42
Forward PE	6.30
Profit Margin	0.25%
Debt to Equity Ratio	-2.21

Volume	1,623,700
Avg Vol	4,452,100
Day's Range	N/A - N/A
Shares Out	162.68M
Stochastic %K	3%
Beta	0.17
Analysts	Sell
Price Target	$4.28